Ajanta Pharma Limited (NSE: AJANTPHARM), ISIN INE031B01049 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
AJANTPHARM last traded at ₹3409.95 (+0.37%), with a 52-week range of ₹2335.00 to ₹3598.40 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 63.48%, FIIs 7.68%, DIIs 21.80%, mutual funds 18.10%.
EquiSense Score (ECS): 76/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.